Shiitake Mushroom — Hermetica Encyclopedia
Mushroom · Mushroom/Fungi

Shiitake Mushroom

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Shiitake mushroom contains lentinan, a high-molecular-weight β-1,3/1,6-glucan that adopts a triple-helical conformation activating macrophages, NK cells, T lymphocytes, and cytokine cascades to modulate innate and adaptive immunity. In vitro studies demonstrate that alkali-extracted lentinan fractions at 25–400 µg/mL significantly inhibit viability of HT-29 and SW480 colon cancer cell lines through enhanced apoptosis induction, though large-scale human clinical trial data quantifying effect sizes remain limited.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary Keywordshiitake mushroom benefits
Shiitake Mushroom close-up macro showing natural texture and detail — rich in dendritic cells, and nk cells, il-1β
Shiitake Mushroom — botanical close-up

Health Benefits

**Immunomodulation**
Lentinan β-glucan activates macrophages, T cells, B cells, and natural killer cells while stimulating pro-inflammatory cytokine and nitric oxide production, enhancing both innate and adaptive immune defense responses.
**Anticancer Activity**
Polysaccharide fractions (25–400 µg/mL) inhibit colon cancer cell (HT-29, SW480) proliferation through apoptosis induction, and lentinan has been studied as an adjunct to chemotherapy in Japan to reduce tumor angiogenesis and restore immune competence.
**Antioxidant Protection**
Methanolic extracts from log-cultivated shiitake show ABTS radical scavenging IC50 of 1.90 mg/mL and higher ferric-reducing power than sawdust-cultivated counterparts, attributable to phenolic compounds with a total phenolic content of approximately 5.06 mg GAE/g dry extract.
**Cholesterol Reduction**
Eritadenine, a unique adenosine derivative found at concentrations up to 10.23 mg/L in mycelial bioreactor media, inhibits S-adenosylhomocysteine hydrolase activity and alters phospholipid metabolism, contributing to measurable reductions in serum cholesterol in animal models.
**Anti-Inflammatory Effects**
Bioactive polysaccharides and phenolic compounds suppress pro-inflammatory mediators and restore gut microbiome balance and epithelial barrier integrity, with secondary metabolites lentamycin A/B and lentysine providing additional direct antimicrobial contributions.
**Gut Microbiome Support**
Shiitake's high β-glucan and dietary fiber content acts as a prebiotic substrate, supporting beneficial Lactobacillus and Bifidobacterium populations while reinforcing intestinal barrier function observed in preclinical models.
**Nutritional Support**
Per 100 g, shiitake provides meaningful quantities of vitamin B12 (4.5–5.5 µg), potassium (1.5 g), zinc (7.7 mg), phosphorus (294 mg), vitamin B6 (0.95 mg), and ergosterol (provitamin D), making it a genuinely nutrient-dense low-calorie functional food.

Origin & History

Shiitake Mushroom growing in China — natural habitat
Natural habitat

Lentinus edodes (synonym Lentinula edodes) is native to East Asia, growing naturally on decaying hardwood trees across China, Japan, and Korea, with China currently producing approximately 72% of the global supply. Traditionally cultivated on logs of oak, chestnut, and other hardwoods, modern commercial production also employs sawdust substrate blocks, though log cultivation yields fruiting bodies with demonstrably higher phenolic content and antioxidant capacity. The mushroom thrives in cool to temperate forest environments and has been deliberately cultivated for over 1,000 years, making it one of the most extensively farmed medicinal fungi in the world.

Shiitake has been cultivated and consumed medicinally in China for over 1,000 years, with written references appearing in the Ming Dynasty pharmacopeia Ben Cao Gang Mu (Compendium of Materia Medica, 1596), where it was recommended to treat conditions including poor circulation, liver disease, exhaustion, and to 'invigorate qi.' In Japan, shiitake (椎茸) achieved cultural status as both a gourmet ingredient and a tonic food, and traditional Japanese medicine (Kampo) incorporated it for strengthening the immune system and reducing hypercholesterolemia. Log-based cultivation (using oak or chestnut logs inoculated with spores) has been practiced in rural China and Japan as an artisanal method for centuries, producing mushrooms with the highest bioactive compound concentrations, a practice now confirmed by modern comparative phytochemical analysis. The identification and isolation of lentinan by Japanese researchers in the 1970s marked a pivotal transition from folk remedy to evidence-investigated pharmaceutical candidate, culminating in its regulatory approval as a biological response modifier for cancer adjunct therapy in Japan.Traditional Medicine

Scientific Research

The clinical evidence base for shiitake mushroom is largely preclinical, consisting predominantly of in vitro cell-line studies and rodent models, with limited well-powered human randomized controlled trials published to date. In vitro studies have rigorously characterized lentinan's antiproliferative effects on HT-29 and SW480 colon cancer lines, and antioxidant assays (ABTS, DPPH, FRAP) have been systematically compared across cultivation methods, providing quantitative biochemical benchmarks. In Japan, injectable lentinan has been investigated as a chemotherapy adjunct in gastric and colorectal cancer patients in small clinical trials, and it is approved as a biological response modifier in some Asian markets, though these trials typically lack the statistical power and methodological rigor of modern Phase III standards. Overall, the evidence is best characterized as preliminary-to-moderate: mechanistically compelling and supported by consistent preclinical data, but lacking the large-scale, placebo-controlled human RCTs with standardized endpoints necessary to establish definitive clinical efficacy or optimal dosing regimens.

Preparation & Dosage

Shiitake Mushroom prepared as liquid extract — pairs with Shiitake β-glucans demonstrate synergistic immunostimulatory activity when combined with other fungal polysaccharides such as those from Ganoderma lucidum (reishi) or Trametes versicolor (turkey tail), as overlapping but non-identical receptor-binding profiles (Dectin-1, TLR-2
Traditional preparation
**Dried Whole Mushroom (Culinary/Food)**
3–10 g per day of dried fruiting bodies as a dietary inclusion; no standardized therapeutic dose established for general consumption
**Polysaccharide/Lentinan Extract (Oral Supplement)**
500 mg to 1,500 mg daily, though human clinical dose-response data are lacking
Typically standardized to 15–40% β-glucan content; common commercial doses range from .
**Injectable Lentinan (Pharmaceutical, Asia-approved)**
1–2 mg administered intravenously or intramuscularly 1–2 times per week as adjunct cancer immunotherapy; this form is not approved by FDA or EMA for therapeutic use
**Hot Water Extract**
Traditional preparation involving simmering dried mushrooms at 80–100°C for 30–60 minutes to solubilize polysaccharides; used in decoctions in Chinese and Japanese herbal practice.
**Alkali Extraction (Research/Industrial)**
5% NaOH with 0.05% NaBH₄ followed by ultrasonication used to isolate high-molecular-weight glucan fractions; not a consumer-facing format but informs standardization benchmarks.
**Mycelial Biomass Capsules**
500 mg–1 g per dose; eritadenine content variable and often not standardized on labels; bioreactor-produced mycelia can yield up to 10
23 mg/L eritadenine.
**Timing**
No established optimal timing; with meals is generally recommended to improve tolerability and potentially co-present lipid substrates for eritadenine activity.

Nutritional Profile

Per 100 g of dried shiitake fruiting bodies: calories approximately 296 kcal; protein 9–11 g; carbohydrates 65–75 g (including 11–14 g dietary fiber predominantly as β-glucans); fat 1–2 g. Micronutrients include potassium (~1,500 mg), phosphorus (~294 mg), zinc (~7.7 mg), copper (~5.2 mg), and selenium (~26 µg). Vitamins present include B6 (0.95 mg/100 g), B12 (4.5–5.5 µg/100 g — notably high for a plant-derived food), vitamin C (2.1–3.5 mg), vitamin D as ergosterol/vitamin D2 (~4 µg), and vitamin E (~10 µg). Primary phytochemicals include lentinan β-glucan (concentration highly extraction-method dependent), total phenolics at 4.86–5.06 mg GAE/g dry extract, eritadenine (variable; up to 10.23 mg/L in mycelial preparations), galactitol (44.43% AUC by GC/MS), trehalose (11.30% AUC), fumaric acid (up to 3.88 mg/g in optimized fruiting bodies), and secondary metabolites lentamycin A/B, lentithionine, and lentysine. Bioavailability of β-glucans is influenced by their molecular weight, triple-helical conformation, and degree of branching; high-molecular-weight forms show superior immunoreceptor engagement; heat and extreme pH processing can degrade triple-helical structure and reduce activity.

How It Works

Mechanism of Action

Lentinan, a high-molecular-weight β-1,3/1,6-glucan, binds pattern recognition receptors including Dectin-1 and complement receptor 3 (CR3/CD11b) on macrophages and dendritic cells, triggering NF-κB and MAPK signaling cascades that upregulate IL-1β, IL-6, TNF-α, and IFN-γ secretion while activating NK cell cytotoxicity; the triple-helical conformation of high-molecular-weight fractions is essential for this receptor engagement and explains why extraction method critically determines biological activity. Phenolic compounds exert direct radical scavenging via hydrogen atom transfer and single electron transfer mechanisms, while also inhibiting lipid peroxidation enzymes, contributing to the observed ABTS IC50 values of approximately 1.90–2.38 mg/mL depending on cultivation substrate. Eritadenine competitively inhibits S-adenosylhomocysteine hydrolase, reducing hepatic phosphatidylcholine synthesis and increasing cholesterol export, thereby lowering circulating LDL levels in animal studies; it is produced preferentially by mycelial cultures under controlled bioreactor conditions (250 rpm, pH 5.7). Secondary metabolites including lentithionine and lentamycin A/B demonstrate direct membrane-disrupting antimicrobial and antiviral activity, while the polysaccharide matrix supports gut epithelial integrity by upregulating tight junction proteins ZO-1 and occludin in preclinical colitis models.

Clinical Evidence

No large, well-powered phase III randomized controlled trials with clearly reported sample sizes and standardized effect sizes were identified in the available literature for oral shiitake supplementation in healthy or clinical human populations. Japanese clinical investigations of parenteral lentinan as an immunopotentiating adjunct to cisplatin-based chemotherapy in gastric cancer reported improvements in survival metrics in small cohorts, but these studies were conducted decades ago with limited blinding and variable patient selection. A handful of small human pilot studies have examined immune cell count changes and cytokine profiles after dietary shiitake consumption, with some reporting increases in NK cell activity and secretory IgA, but these trials are insufficiently powered to yield definitive conclusions. Confidence in translating preclinical findings to reliable clinical outcomes remains moderate at best; further well-designed human RCTs with standardized extracts, validated biomarkers, and pre-registered protocols are required.

Safety & Interactions

Shiitake is broadly recognized as safe when consumed as food; however, a documented adverse reaction known as 'shiitake dermatitis' (flagellate erythema) can occur in sensitive individuals who consume raw or insufficiently cooked mushrooms, caused by lentinan triggering a toxic rather than allergic skin response, typically resolving within 1–3 weeks. Rare cases of hypersensitivity pneumonitis ('mushroom worker's lung') have been reported in occupationally exposed individuals through inhalation of spores during cultivation, and eosinophilia has been noted in a small number of case reports following high-dose extract consumption. No well-characterized pharmacokinetic drug interactions have been formally established, but due to immunostimulatory mechanisms, theoretically shiitake extracts may reduce the efficacy of immunosuppressive agents (e.g., cyclosporine, tacrolimus, corticosteroids) and could potentiate the activity of other immune modulators; individuals on immunosuppressive therapy post-transplant or for autoimmune disease should consult a physician before supplementing. No maximum tolerated oral dose has been established in human studies, and safety data in pregnancy and lactation are absent from the peer-reviewed literature; culinary quantities are considered acceptable during pregnancy but high-dose extract supplementation is not recommended without medical supervision.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Lentinula edodes (Berk.) PeglerLentinus edodes (Berk.) SingerShiitake椎茸 (Shiitake, Japanese)香菇 (Xiānggū, Chinese)Black Forest MushroomGolden Oak Mushroom

Frequently Asked Questions

What is lentinan and how does it work in shiitake mushroom?
Lentinan is a high-molecular-weight β-1,3/1,6-glucan polysaccharide extracted from shiitake mushroom fruiting bodies, notable for its triple-helical conformation that is essential for biological activity. It binds Dectin-1 and complement receptor 3 (CR3) on macrophages and dendritic cells, triggering NF-κB signaling that upregulates cytokines (IL-1β, IL-6, TNF-α) and activates NK cells and T lymphocytes. In vitro, lentinan fractions at concentrations of 25–400 µg/mL have been shown to inhibit HT-29 and SW480 colon cancer cell viability through enhanced apoptosis induction.
What is the recommended daily dosage of shiitake mushroom extract?
No universally established therapeutic dose for oral shiitake extract has been confirmed through large-scale human clinical trials. Commercial supplements are typically standardized to 15–40% β-glucan content and offered at doses of 500 mg to 1,500 mg per day, while culinary consumption of 3–10 g of dried mushroom daily is traditional and considered safe. Injectable pharmaceutical lentinan (1–2 mg IV/IM, 1–2×/week) has been used in Japan as a cancer adjunct but is not approved by the FDA or EMA; consumers should verify beta-glucan standardization on product labels.
Does shiitake mushroom lower cholesterol?
Shiitake contains eritadenine, a unique adenosine derivative that inhibits S-adenosylhomocysteine hydrolase, thereby altering hepatic phospholipid metabolism and reducing circulating LDL cholesterol levels, as demonstrated in multiple rodent studies. Bioreactor-grown mycelial preparations can yield up to 10.23 mg/L eritadenine, though concentrations in commercial dried mushrooms and supplements vary considerably. While animal model evidence is consistent, well-powered human RCTs specifically quantifying the cholesterol-lowering effect of dietary or supplemental shiitake are currently insufficient to establish a definitive clinical recommendation.
Are there any side effects or safety concerns with shiitake mushroom?
The most clinically documented adverse reaction is 'shiitake dermatitis,' a flagellate (whip-like striped) skin erythema triggered by lentinan in raw or undercooked mushrooms, which typically resolves within 1–3 weeks after discontinuation; thorough cooking eliminates this risk in most cases. Rare cases of hypersensitivity pneumonitis have been reported in mushroom farm workers through spore inhalation, and eosinophilia has been noted in a small number of high-dose extract case reports. Individuals taking immunosuppressive drugs (cyclosporine, tacrolimus, systemic corticosteroids) should use caution due to potential immunostimulatory interactions, and high-dose extracts are not recommended during pregnancy or lactation due to absent safety data.
Is log-grown shiitake better than sawdust-grown for health benefits?
Comparative phytochemical analysis confirms that log-cultivated shiitake produces fruiting bodies with significantly higher total phenolic content (approximately 5.06 ± 0.62 mg GAE/g dry extract) and superior antioxidant activity (ABTS IC50 ~1.90 mg/mL) compared to sawdust-cultivated specimens (4.86 ± 0.68 mg GAE/g; ABTS IC50 ~2.38 mg/mL). Log cultivation more closely replicates natural hardwood forest growing conditions, promoting a more complex secondary metabolite profile. For consumers prioritizing antioxidant and phenolic content, log-grown shiitake or supplements specifying log-cultivated sourcing represent the higher-bioactivity option, though both cultivation methods yield meaningful β-glucan content.
Can shiitake mushroom be taken with immunosuppressant medications?
Shiitake mushroom's immunomodulatory effects may potentially interfere with immunosuppressant drugs used after organ transplantation or for autoimmune conditions, as lentinan actively enhances immune cell activation. Individuals taking medications like azathioprine, mycophenolate, or corticosteroids for immune suppression should consult their healthcare provider before supplementing with shiitake. The activation of macrophages, T cells, and natural killer cells could theoretically counteract the intended effects of these medications.
Does fresh shiitake mushroom provide the same health benefits as extract supplements?
Fresh shiitake mushrooms contain beneficial compounds including lentinan and other polysaccharides, but standardized extracts typically deliver significantly higher concentrations of bioactive β-glucans in smaller serving sizes. Clinical studies demonstrating immunomodulation and anticancer effects generally use concentrated extracts (often standardized to specific polysaccharide percentages) rather than whole food amounts. While fresh mushrooms contribute nutritional value, supplement extracts are engineered to provide the therapeutic dosages shown in research.
Is shiitake mushroom beneficial for people undergoing cancer treatment?
Research shows shiitake polysaccharides can induce apoptosis in colon cancer cells in vitro and may support immune function during chemotherapy through macrophage and natural killer cell activation. However, shiitake should only be used as a complementary approach under oncologist supervision, as its immunostimulating properties could theoretically interact with certain cancer treatments. Clinical evidence in human cancer patients is limited, and timing relative to chemotherapy or radiation is critical to discuss with your oncology team.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.